SCHEMBL8549767

SCHEMBL8549767

CCCCOc1ccc2[nH]cc(CN(C)C)c2c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
HTR1A P08908 9/20 0.43
HTR1B P28222 9/20 0.43
HTR1D P28221 8/20 0.43
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
TLR7 Q9NYK1 1/20 0.39
KDM4E B2RXH2 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC6A4 P31645 2/20 0.38
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549160 0.94 HTR2A (0.45) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8545440 0.88 HTR1A (0.55) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8546408 0.82 HTR1A (0.52) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL15678352 0.82 HTR2A (0.56) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8545081 0.81 HTR1A (0.55) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8549571 0.81 HTR1B (0.37) HTR2AHTR1AHTR1BHTR1DTHRA
SCHEMBL8545281 0.80 HTR2A (0.56) HTR2AHTR2CHTR2BHTR1AHTR1D
SCHEMBL8869200 0.77 SLC6A4 (0.51) HTR2AHTR2CHTR2BHTR1AKDM4E
SCHEMBL8544351 0.77 HTR2A (0.45) HTR2AHTR2CHTR2BHTR1AHTR1B
SCHEMBL8543442 0.75 HTR1A (0.54) HTR2AHTR2CHTR1AHTR1BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed